Literature DB >> 891608

The dynamics of dopamine metabolism in various regions of rat brain.

F Karoum, N H Neff, R J Wyatt.   

Abstract

Dopamine metabolism was studied in various regions of rat brain by following the decline of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxy-4-hydroxyphenylacetic acid (HVA) from brain after treatment with pargyline, or from the accumulation of the acids after treatment with probenecid. The decline of DOPAC and HVA after pargyline treatment appeared exponential in all regions of brain studied with half-lives of about 13 min for HVA and 6.5 min for DOPAC. DOPAC was the major metabolite of dopamine, with various brain regions producing between 2-5 times more DOPAC than HVA. HVA accumulated after treatment with probenecid but the accumulation in 1 h did ot account for all of the HVA apparently eliminated from brain. DOPAC accumulated in some regions of brain (medulla, hypothalamus and midbrain) and not in others (cerebellum, cortex, striatum and hippocampus) after probenecid treatment. We conclude that dopamine metabolism is not uniform in brain and that the accumulation of DOPAC and HVA in brain after probenecid treatment only accounts for a minor fraction of the dopamine formed in brain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891608     DOI: 10.1016/0014-2999(77)90304-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.

Authors:  Zili Luo; Katelin E Ahlers-Dannen; Mackenzie M Spicer; Jianqi Yang; Stephanie Alberico; Hanna E Stevens; Nandakumar S Narayanan; Rory A Fisher
Journal:  JCI Insight       Date:  2019-05-23

2.  Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Dopamine and serotonin metabolism in striatum and in the septohippocampal pathway of the Snell dwarf mouse.

Authors:  E Kempf; G Fuhrmann; G Thiriet; A Ebel
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

4.  Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; G R Breese; R B Mailman
Journal:  J Chromatogr       Date:  1981-10-09

5.  Differential sensitivity of hypothalamic dopaminergic and noradrenergic neurones to pharmacological manipulation.

Authors:  F Karoum; S G Speciale; R J Wyatt
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

6.  3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.

Authors:  P M Beart; A L Gundlach
Journal:  Br J Pharmacol       Date:  1980-06       Impact factor: 8.739

7.  Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.

Authors:  F Karoum; S J Chrapusta; R Brinjak; A Hitri; R J Wyatt
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

8.  DL-threo-DOPS as a precursor of noradrenaline.

Authors:  A Reches; V Jackson-Lewis; S Fahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

9.  Mathematical insights into the effects of levodopa.

Authors:  Michael C Reed; H Frederik Nijhout; Janet A Best
Journal:  Front Integr Neurosci       Date:  2012-07-04

10.  Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.

Authors:  Janet A Best; H Frederik Nijhout; Michael C Reed
Journal:  Theor Biol Med Model       Date:  2009-09-10       Impact factor: 2.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.